Radiology and Oncology | Ljubljana | Slovenia | www.radioloncol.com Radiol Oncol 2021; 55(3): 268-273. doi: 10.2478/raon-2021-0018 268 research article MRI of the Morel-Lavallée lesion – a case series Tajda Srot Volavc1, Mitja Rupreht1,2 1 Radiology Department, University Medical Center Maribor, Maribor, Slovenia 2 Medical Faculty, University of Maribor, Maribor, Slovenia Radiol Oncol 2021; 55(3): 268-273. Received 29 December 2020 Accepted 16 February 2021 Correspondence to: Assist. Prof. Mitja Rupreht, M.D., Ph.D., Radiology Department, UMC Maribor, Ljubljanska 5, 2000 Maribor, Slovenia. E-mail: mitja.rupreht@ukc-mb.si Disclosure: No potential conflicts of interest were disclosed. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Introduction. The aim of the study was to review the appearances of Morel-Lavallée (ML) lesions on magnetic resonance imaging (MRI). Patients and methods. 14 patients diagnosed with the ML lesion on MRI were analysed retrospectively (mean age = 35 years). Mechanism of injury, time frame from injury to MRI, location, shape, T1 and proton-density fat-suppression (PDFS) signal intensity (SI), presence of a (pseudo)capsule, septations or nodules within the collection, mass effect and fluid-fluid levels were analyzed. The Mellado and Bencardino classification was utilized to classify the lesions. Results. In most cases, mechanism of injury was distortion. Mean time frame between the injury and MRI was 17 days. Lesions were located around the knee in 9 patients and in the peritrochanteric region in 5 patients. Collections were fusiform in 12 patients and oval in 2 patients. 9 collections were T1 hypointense and PDFS hyperintense. 4 collections had intermediate T1 and high PDFS SI. 1 collection had intermediate T1 and PDFS SI. (Pseudo)capsule was noted in 3 cases. Septations or nodules were found in 4 cases. According to the Mellado and Bencardino, collections were clas- sified as seroma (type 1) in 9, subacute hematoma (type 2) in 1 and chronic organizing hematoma (type 3) in 4 cases. Conclusions. Characteristic features of ML lesion include a fusiform fluid collection between the subcutaneous fat and the underlying fascia after shearing injury. Six types can be differentiated on MRI, with the seroma, the subacute hematoma and the chronic organizing hematoma being the commonest. Key words: Morel-Lavallée; soft-tissue injury; hematoma; magnetic resonance imaging Introduction Morel-Lavallée (ML) lesion has initially been presented by a French surgeon Victor Auguste Francois Morel-Lavallée in 1863, who described it as fluid collection which dissects the subcutaneous fat tissue.1 In most cases, it is a post-traumatic, closed, de- gloving soft-tissue injury caused by direct trauma or shearing forces, resulting in abrupt separation of skin and subcutaneous tissue from the underly- ing fascia.2-4 Consequently, a dead space is formed, which can potentially fill with haemolymph, debris and fat, resulting in a formation of heterogeneous collection.2-3,5-6,7-9 Peritrochanteric region is particularly sensitive to this injury because of the increased mobility of the soft tissue in this area, the superficially located bone, strong underlying fascia lata attaching to the iliotibial band and a rich vascular plexus piercing the fascia lata.5,7,8 Clinically it usually presents as an enlarging pain- ful swelling.2 Clinical presentation and the imaging techniques are keys to a diagnosis. Ultrasound (US) is an excellent imaging modality for the evaluation of superficial soft tissues and collections. However, owing to both high contrast resolution and demon- stration of deep tissues, magnetic resonance (MRI) is a gold standard for the identification and evalua- tion of the ML lesion.2-4,6-8,10,11 Radiol Oncol 2021; 55(3): 268-273. Srot Volavc T and Rupreht M / MRI of the Morel-Lavallée lesion 269 ML lesion can present with various shapes and signal intensities in standard MRI sequences due to the different stages and contents of the lesions. This can lead to underrecognition and misinterpre- tation of the ML lesions by the radiologists. In or- der to prevent complications such as infections or extensive tissue necrosis it is essential to diagnose and manage the lesion in a timely manner.2-4,7,10 In the literature, several forms of ML lesions have been described. In 2005, an extensive six-stage imaging-based classification on the shape of lesion, signal intensity (SI) on T1 and T2-weighted images, presence of the fibrous capsule, contrast enhance- ment and sinus tract formation capsule was pro- posed by Melado and Bencardino (Table 1).11 A type 1 ML lesion is a seroma, exhibiting fluid- like characteristics. It is seen as homogeneously hypointense on T1 and hyperintense on T2 MRI (Figure 1).5,12 It can be acute or chronic and is most- ly noncapsulated.5,11 A type 2 ML lesion is a subacute hematoma, which appears homogenously hyperintense on both, T1 and T2 MRI.5,9,12 The cause of high T1 SI is the presence of methaemoglobin. In the early subacute hematoma, the methaemoglobin is first observed in the periphery. With time it becomes more homogeneously distributed.5,11,13 These le- sions mostly have a hemosiderin-rich capsule on T1- and T2-WI. From time to time internal inhomo- geneity can be seen, due to the fluid-fluid levels, internal septations and entrapped fat globules.5,13 Occasionally, patchy internal enhancement af- ter intravenous contrast administration can be ob- served due to the presence of capillaries, which can lead to false interpretation of the lesion as a soft- tissue tumour. The subacute hematomas can be further divided in early and late subacute hemato- mas. The early ones are more homogeneous, while the late ones often present with a fibrous capsule and are seen as heterogeneous.5,14 A type 3 ML lesion is a chronic organizing he- matoma, with hypo- or intermediate SI on T1 and as heterogeneous intermediate on T2 sequences. The heterogeneous signal is seen due to the con- tent of the lesion: hemosiderin granulation tissue, necrotic debris, fibrin and blood clots (Figure 2).11 Because of neovascularization and granulation tis- sue, patchy internal and peripheral enhancement can be seen on post-contrast MRI.5,12 These types of lesions may be surrounded by a hemosiderin-rich fibrous capsule.5,14 Type 4-6 ML lesions are the chronic ones, of- ten presenting atypically. A type 4 ML lesion is a closed fatty tissue laceration with a perifascial dissection. It can be associated with or without a serous/haemorrhagic collection.5,11 The collection is seen with low T1 SI and high T2 SI. It is not sur- rounded by a capsule and it enhances variably.5,14 A type 5 ML lesion is located perifascially and has a pseudonodular appearance. Occasionally, a peripheral enhancement and skin retraction are seen.5,11 A type 6 ML lesion is an infected lesion, it often presents with a thick capsule, internal septations, peripheral fluid leakage, inflammation of the adja- cent fat tissue and fascia and sometimes even with an associated sinus tract.5,11 The aim of our study was to retrospectively analyse the series of patients with ML lesions based on the Mellado-Bencardino classification and evaluate its presentations on MRI. FIGURE 1. Morel-Lavallee lesion type 1. A 33-years-old professional skier 2 weeks after a fall. A large fusiform collection (arrows) between the subcutaneous fat and fascia lata demonstrating low signal intensity (SI) on T1 WI (A) and high SI on proton density fat-saturated image (PDFS) (B) in coronal plane indicating clear fluid i.e. seroma. FIGURE 2. ML lesion type 3. A 34-year-old male after a distortion. On axial proton- density fat-suppression (PDFS) MRI (A) a fusiform fluid collection with hypointense debris is demonstrated between the deep subcutaneous fat and layers of medial patelofemoral ligament (arrows). On T1 weighted sagital image (B), in moderately hypointense collection several fat globules are visible (thin arrow). A B A B Radiol Oncol 2021; 55(3): 268-273. Srot Volavc T and Rupreht M / MRI of the Morel-Lavallée lesion270 Patients and methods The study design was a single-center retrospective review, performed accordingly to the Declaration of Helsinki and approved by the local ethics com- mittee. The search identified fourteen patients; ten male and four female. Their age ranged between 11–67 years with the mean age 34.8 years. The examinations were performed with various MRI scanners. MRI protocol consisted of T1 sequence in at least one plane and proton density fat-sup- pressed sequences (PDFS) in several planes. In ad- dition, T2 sequence without fat suppression was utilized several times. Intravenous (I.V.) contrast was not administered in any case. The mechanism of injury as well the time frame between injury and MRI were recorded, when provided. Additionally, the imaging reports and MRI images were reviewed. Also, the possible ad- ditional imaging modalities were identified. The following characteristics of the MR-images were evaluated by the radiology resident (first author) and musculoskeletal (MSK) radiologist with 14 years of experience (second author) in consensus: location, shape, signal intensity (SI), presence of a (pseudo) capsule, septations or nodules within the collection, mass effect and fluid-fluid levels. Results Mechanism of injury and time frame between the injury and MRI In five patients out of fourteen (30.1%) the mecha- nism was distortion, in 3/14 patients (21.4%) fall, 2/14 (14.3%) were athletes without acute injury, 1/14 (7.1%) patient kneeled and one (7.1%) was in- jured in a motor vehicle accident. In 2/14 patients (14.3%), the mechanism of injury was unknown. For 11/14 patients (78.6%) the time frame be- tween the injury and MRI was 4 days to 4 months, with mean time of 17 days. For 3/14 patients (21.4%) the time frame was unknown. Additional ultrasound Only one patient (7.1%) had an ultrasound before the MRI. One patient (7.1%) had a follow-up ultra- sound. MRI characteristics Location and shape The collections were located around the knee in 9/14 patients (64.3%) and in the peritrochanteric region in 5/14 (35.7%) patients. The majority (12/14, 85.7%) of collections was fusiform and only 2/14 (14.3%) had oval shape. MRI signal intensity and lesion classification Most collections (9/14, 64.3%) were T1 hypointense and PDFS hyperintense (Figure 1). 4/14 (28.5%) collections had intermediate T1 and high PDFS SI (Figure 2). 1/14 (7.1%) collection had intermediate T1 and PDFS SI. (Pseudo)capsule was noted in 3/14 cases (21.4%). Septations or nodules were found in 4/14 (28.5%) cases. No cases with mass effect or fluid-fluid levels were observed. Additionally, in 5/14 (35.7%) cases fat globules were found. Also, in 10/14 (71.4%) cases the oedema of subcutaneous fat was noted without lacerations. The collections were classified according to the Mellado-Bencardino classification as seroma – type 1 in 9/14 (64.3%), subacute hematoma – type 2 in 1/14 (7.1%) and chronic organizing hematoma – type 3 in 4/14 (28.5%). TABLE 1. MRI classification of Morel-Lavallee lesions according to Mellado-Bencardino12 Lesion type T1W T2W Morphology Other Type 1 - Seroma Homogenously hypointense seroma Hyperintense collection Laminar No evidence of outer capsule formation Type 2 – Subacute hematoma Homogenously hyperintense Homogenously hyperintense Oval Presence of methaemoglobin Thin capsule formation Type 3 – Chronic organizing hematoma Hypointense Heterogeneous hypointense/ isointense Oval Thick capsule formation Capsular and internal enhacement on postcontrast sequences Type 4-Closed laceration Hypointense Hyperintense Linear No capsule formation Type 5-Small, rounded pseudonodular appearance Variable Variable Round Variable capsule formation Type 6-Superimposed infection Variable Variable Variable sinus tract Thick enhancing capsule Radiol Oncol 2021; 55(3): 268-273. Srot Volavc T and Rupreht M / MRI of the Morel-Lavallée lesion 271 Discussion To our knowledge, the presented study is one of larger cohorts in the published literature, in par- ticular with the focus on the MRI. ML lesions most commonly occur around the greater trochanter, al- though they can be found around the knee, trunk, peri-scapular etc.2-3,5-7,10,11,15 Sometimes the collec- tions may extend through thin sinus tract far from the original location (Figure 3). The location of the ML lesion around the knee was more frequent in our cohort than previously reported. Frequently, small fluid collections in the deep subcutaneous tissues around the knee joint are interpreted as simple seroma or hematoma whereas they could be also described as ML lesion. Alternatively, in the clinical practice, prepatellar fluid collections are commonly interpreted as a bursitis, which may represent the differential diagnosis. Prepatellar ML lesions often extend medially or laterally and proximally to the mid-thigh whereas a prepatellar bursitis does not extend beyond the mid-coronal plane and the boundaries of normal and slightly swollen bursa.16,17 The exact definition of loca- tion might represent a challenge in the definition and classification of the ML lesions in the future. However, the distinction may not be clinically rele- vant as treatment is often the same. A chronic hem- orrhagic prepatellar bursitis may mimic a type 3 ML lesion.14,18 The shapes of the lesions were in line with the previous reports.5 Septations and nod- ules, as well as fat globules, were less frequent in the presented group than in a published literature5, probably owing to a small patient group. The pres- ence of intralesional fat globules (Figure 4) is not pathognomonic, although they may be found in some subacute hematomas.19 However, their find- ing may contribute to the characterization of the collection as the ML lesion.20,21 On the other hand, they are not among criteria of Mellado-Bencardino classification. Most collections in the study group were clas- sified as the Type 1 lesions. This could possibly be explained with the relative short time frame be- tween the injury and the MRI. We could not find the time frame data in previous published reports. The results of less frequent type 2 and type 3 le- sions are in line with other reports.5 We did not encounter type 3–6 lesions according to Mellado-Bencardino classification, possibly ow- ing to their rarity, variable presentations on MRI, short time-frame between the injury and MRI, and a small patient group. Similar results were found in other small series.5 In the presented cohort, routine PDFS sequences were utilized as fluid-sensitive fat-suppressed se- quences. The Mellado-Bencardino classification is based on T1/T2 MRI protocol, as it was most prob- ably derived from MRI of soft tissue tumours as well as from other MSK protocols in mid-2000s, when it was introduced. The PDFS sequence was FIGURE 4. Fat globule and concomitant injury. In this 14-year-old boy with unknown time and mechanism of injury, a small fusiform fluid collection is visible at the right side between deep subcutaneous fat and fascia lata with low T1 (A) and high proton-density fat-suppression (PDFS) (B) SI (thin arrows) on coronal images. Note also a large fat globule in the lesion (short thick arrows). In addition, on the left side (C), an small avulsion of the sartorious tendon off the anterior superior iliac spine is visible (long thick arrow). FIGURE 3. Extension of the Morel-Lavallée (ML) lesion. Same patient as in the Figure 1. On axial proton-density fat-suppression (PDFS) images, a thin communication (thin arrows) between gluteus maximus muscle and the deep gluteal fat connects the primary lesion (thick short arrow) and another collection posteriorly (thick arrow). Note also the mild oedema signal of the gluteus maximus muscle and gluteal fat indicating contusions. A B C Radiol Oncol 2021; 55(3): 268-273. Srot Volavc T and Rupreht M / MRI of the Morel-Lavallée lesion272 mostly not utilized routinely in the MSK MRI at the time, however owing to its robustness it has been a MSK workhorse since 2010, when the routine role of non-fat-suppressed T2 sequence was reduced. Therefore, to be strict, the classification in the pre- sented series could be characterized as »Mellado- Bencardino related«. Furthermore, as in routine MSK MRI trauma settings, no contrast had been administered in the presented series. However, owing to other typical findings, follow-up exami- nation with contrast was not indicated in any case. Modified MRI protocols, as well as not encounter- ing types 3–6 lesions, might both imply the possi- ble opportunity for an update and simplification of the Mellado-Bencardino classification to the three stages in the future. This should be verified in stud- ies with larger patient cohorts and clinical correla- tion. The specific location between the subcutaneous tissue and the fascia, the imaging signs and knowl- edge of the classification system may all be helpful in the differential diagnosis with other fluid-filled collections in the soft tissues.5 In addition to bursi- tis, described above, other differential possibilities include soft tissue masses and other posttraumatic collections. Among soft tissue masses, sarcomas represent the most dangerous possibility which can mimic type 1 or 3 ML lesion. In short, sarco- mas, as vascularized tumours, mostly demonstrate contrast enhancement, whereas collections do not. However, in most cases, particularly in trauma set- ting, I.V. contrast is not administered, as it was not in the presented cohort, as mentioned. Therefore, caution is warranted and low threshold to follow- up MRI with contrast or US Doppler examination (the role of US contrast in these settings is yet to be evaluated) should be set, particular in growing masses. Other possible differential diagnoses include fat necrosis, where MRI signal depends on timing af- ter trauma. It may appear spiculated or more lami- nar22 and may sometimes mimic a type 4 ML le- sion.11 Another possibility is pseudolipoma, which can develop after blunt trauma as well as iatrogenic after surgery and hematoma.11 On MRI, it usually presents as subcutaneous lipomatous mass with- out capsule or contrast enhancement.23 Owing to their superficial location, most of ML lesions can be detected with ultrasound (US). Interestingly, only one patient in the presented cohort had had US examination performed before the MRI. This could be explained with the lack of data of possible US examinations performed out- side our institution. Mostly, similar as on MRI, the US appearance depends on their age, often with heterogenous echogenicity. The latter depends on the degradation stage of the blood products; acute and subacute (up to a month) lesions will appear heterogeneous with irregular margins and lobular shape. Over the time, the blood products will liq- uefy and become more hypoechoic. Chronic lesions (more than 18 months) are more often homogenous with smooth margins.7,20,21,24 MRI, however, enables more detailed analysis of deeper tissues and dem- onstration of possible concomitant muscle, nerve and bone injuries (Figures 4, 5). In our opinion, it is therefore preferred imaging modality at least before possible invasive therapeutic procedures or clinical suspicion of possible extension in different compartments, larger collections, superinfections or unclear differential diagnosis.5 Nevertheless, US could be an excellent method for the follow-up of the lesion, particularly in conservatively managed cases, as well as in suspected complications after invasive treatment. Computed tomography (CT) has minor role in the evaluation of the ML lesions. They may, how- ever, incidentally show-up in the examinations, performed for the evaluation of possible bone inju- ries. On CT, they may demonstrate with fluid-fluid FIGURE 5. Concomitant injuries. Same patient as in Figure 1 and 3. In proton-density fat-suppression (PDFS) coronal image, a mild hyperintensity of adductor muscles is visible (thick arrow) indicating mild distension without fibre disruption. In addition, note secondary cleft sign (thin arrow) at the lower right edge of the pubic symphysis indicating possible injury of the rectus/adductor aponeurosis. In such case, a dedicated MRI examination might be warranted. Radiol Oncol 2021; 55(3): 268-273. Srot Volavc T and Rupreht M / MRI of the Morel-Lavallée lesion 273 levels and lower densities than simple hematomas owing to mixing of low-density lymphatic fluid.4 Therefore, they may be easily overlooked, especial- ly in the bone window. Treatment of the ML lesion depends on the sta- dium. It varies from compression banding, aspira- tion or incision and evacuation, with or without injection of sclerosing agents.14,25 The lack of US data in the presented cohort rep- resents a limitation of the presented study. Another limitation could be the lack of the data of further clinical and imaging management because most patients were outpatients who were lost to follow- up. However, both were not primary purposes of the study. Conclusions Morel-Lavallée lesion results from the traumatic separation of the skin and subcutaneous fat from the underlying fascia where a fusiform fluid col- lection is demonstrated on imaging. On MRI, six types of ML lesion can be differentiated, with the seroma, the subacute hematoma and the chronic organizing hematoma being the most frequent presentations. Knowledge of the most common locations, imaging signs and classification system may be helpful in the differential diagnosis. The re- sults of the presented study, as well as the modified MRI protocols in the last decade, might suggest the opportunity for the possible update and simplifica- tion of the Mellado-Bencardino classification. References 1. Morel-Lavalle M. Decollements traumatiques de la peaue et de couches. Arch Gen Med 1863; 1: 20-38, 172-200, 300-332. 2. Husein K, White B, Sampson M, Gupta S. Pictorial review of Morel-Lavallee lesions. J Med Imaging Radiat Oncol 2019; 63: 212-15. doi: 10.1111/1754- 9485.12854 3. Myrick KM, Davis S. Morel-Lavalee injury - a case study. Clin Case Rep 2018; 6: 1033-9. doi: 10.1002/ccr3.1518 4. Diviti S, Gupta N, Hooda K, Sharma K, Lo L. Morel-Lavallee lesions review of patophysiology, clinical findings, imaging findings and management. J Clin Diagn Res 2017; 11: TE01-04. doi: 10.7860/jcdr/2017/25479.9689 5. De Coninck T, Vanhoenacker F, Verstaete K. Imaging features of Morel- Lavallee lesions. J Belg Soc Radiol 2017; 101: 15. doi: 10.5334/jbr-btr.1401 6. Christian D, Leland HA, Osias W, Eberlin S, Howell L. Delayed presentation of a chronic Morel-Lavallee lesion. J Radiol Case Rep 2016; 10: 30-9. doi: 10.3941/jrcr.v10i7.2698 7. McLean K, Popovic S. Morel-Lavallee lesion: AIRP best cases in radiologic- pathologic correlation. Radiographics 2017; 37: 190-96. doi: 10.1148/ rg.2017160169 8. Riemer K, Haukenes O, Kozak A. Morel-Lavallee lesion. Tidsskr Nor Laegeforen 2019; 139. doi: 10.4045/tidsskr.18.0351 9. Gilbert BC, Bui-Mansfield LT, Schyuler D. MRI of a Morel-Lavellee lesion. Am J Roentgeol 2004; 182: 1347-8. doi: 10.2214/ajr.182.5.1821347 10. Nair AV, Nazar PK, Sehkar R, Ramachandran PV, Moorthy S. Morel-Lavallee lesion: a closed degloving injury that requires real attention. Indian J Radiol Imaging 2014; 24: 288-90. doi: 10.4103/0971-3026.137053 11. Mellado JM, Bencardino JT. Morel-Lavallee lesion: review with emphasis on MR imaging. Magn Reson Imaging Clin N Am 2005; 13: 775-82. doi: 10.1016/j.mric.2005.08.006 12. Mellado JM, del Palomar LP, Diaz L, Ramos A, Sauri A. Long-standing Morel-Lavallee lesions of the trochanteric region and proximal thigh: MRI features in five patients. Am J Roentgenol 2004; 182: 1289-94. doi: 10.2214/ ajr.182.5.1821289 13. Bush CH. The magnetic resonance imaging of musculoskeletal hemorrhage. Skeletal Radiol 2000; 29: 1-9. doi: 10.1007/s002560050001 14. Bonilla-Yoon I, Masih S, Patel DB, White EA, Levine BD, Chow K, et al. The Morel-Lavallee lesion: pathophysiology, clinical presentation, imaging fea- tures and treatment options. Emerg Radiol 2014; 21: 35-43. doi: 10.1007/ s10140-013-1151-7 15. Parra JA, Fernandez MA, Encinas B, Rico M. Morel-Lavallee effusions in the thigh. Skeletal Radiol 1997; 26: 239-41. doi: 10.1007/s002560050228 16. Dye SF, Campagna-Pinto D, Dye CC, Shifflet S, Eiman T. Soft-tissue anatomy anterior to the human patella. J Bone Joint Surg Am 2003; 85: 1012-17. doi: 10.2106/00004623-200306000-00005 17. Yahyavi-Firouz-Abadi N, Demertzis JL. Prepatellar Morel-Lavallée effusion. Skeletal Radiol 2013; 42: 151-2. doi: 10.1007/s00256-012-1398-1 18. Borrero CG, Maxwell N, Kavanagh E. MRI findings of prepatellar Morel- Lavallée effusions. Skeletal Radiol 2008; 37: 451-55. doi: 10.1007/s00256- 008-0450-7 19. Yu SJ. Magnetic resonance imaging of posttraumatic soft tissue disorders. Emerg Radiol 1996; 3: 181-94. doi: 10.1007/BF01507739 20. Mukherjee K, Perrin SM, Hughes PM. Morel-Lavallee lesion in an adolescent with ultrasound and MRI correlation. Skelet Radiolog 2007; 36: 43-5. doi: 10.1007/s00256-006-0122-4 21. Neal C, Jacobson JA, Brandon C, Kalume-Brigido M, Morag Y, Girish G. Sonography of Morel-Lavallee lesions. J Ultrasound Med 2008; 27: 1077-81. doi: 10.7863/jum.2008.27.7.1077 22. Chan LP, Gee R, Keogh C, Munk PL. Imaging features of fat necrosis. Am J Roentgenol 2003; 181: 955-9. doi: 10.2214/ajr.181.4.1810955. 23. Theumann N, Abdelmoumene A, Wintermark M, Schynder P, Gailloud M-C, Resnick D. Posttraumatic pseudolipoma: MRI appearances. Eur Radiol 2005, 15: 1876-80. doi: 10.1007/s00330-005-2757-2 24. Choudhary AK, Methratta S. Morel-Lavallée lesion of the thigh: character- istic findings on US. Pediatr Radiol 2010; 40: 49. doi: 10.1007/s00247-010- 1587-9 25. Dawre S, Shashank L, Gupta S, Sreekar H, Gupta AK. The Morel-Lavallee lesion: a review and proposed algorithmic approach. Eur J Plast Surg 2010; 35: 489-94. doi: 10.1007/s00238-012-0725-z